Skip to main content
. 2006 Sep;128(3):247–259. doi: 10.1085/jgp.200609581

TABLE I.

Primers for RNAi Synthesis

Primer Sequence Product size
CON Forward 5′-TCGGGGCTGTGGCTGAGGT-3′ 785 bp
Reverse 5′-TGGTGCTTCGCGTTGATGTGT-3′
1N Forward 5′-ATCCCATCGCCGTGTTTGT-3′ 814 bp
Reverse 5′-ACCTCGATCTTGGCAGTGGAC-3′
1C Forward 5′-GCAACGCCCAGTCAGGA-3′ 793 bp
Reverse 5′-TCATCGTCGAATTGGAGAAC-3′
1S Forward 5′-TGATGCCAGTGGCATTCAC-3′ 509 bp
Reverse 5′-CGCCAGGTGGAAATAGGTT-3′
2N Forward 5′-GATACGTTGGCCCTGTTCATAA-3′ 793 bp
Reverse 5′-GCTCGTCTTTCCGGTAGTGTTC-3′
2C Forward 5′-CCAGCTCGGTCCTAATG-3′ 798 bp
Reverse 5′-CCTCTCCGGTCTTTTGTT-3′
2S Forward 5′-AAACATCACCACTCTGTCGT-3′ 503 bp
Reverse 5′-TTGAGGGGGCCGAGGAT-3′
3N Forward 5′-GATCGGGATATTAAGCACTACA-3′ 783 bp
Reverse 5′-GTCCTCCTCCTTTCTCTTTTTC-3′
4N Forward 5′-TGGCCACGTACTCCTTCTTCCT-3′ 784 bp
Reverse 5′-GCTCTGTCCCCCGCTTCCT-3′

T7 sites (5′-CTAATACGACTCACTATAGGGAG-3′) were added to 5′ ends of both forward and reverse primers.